1-4 of 4
Jingxia Liu
Close
Sort by
Journal Articles

Romidepsin in Combination with Gemcitabine, Oxaliplatin, and Dexamethasone Shows Durable Responses in Aggressive Lymphomas

Neha Mehta-Shah, MD, Peter A. Riedell, MD, Nancy L. Bartlett, MD, Amanda F Cashen, MD, Brad S. Kahl, MD, Todd A Fehniger, MD PhD, Chaz Moreno, Jingxia Liu, MS, PhD, Kenneth R. Carson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1550.
https://doi.org/10.1182/blood-2019-124185
Published: 2019
Journal Articles

Post-Transplant Outcomes in AML Patients ≥ 60 Years of Age Beyond CR1

Dhruv Bansal, MD, Pavan Kumar Bhamidipati, MBBS, MD, Natasha Catherine Edwin, MD, Michael Slade, BA, John F DiPersio, MD PhD, Peter Westervelt, MD PhD, Ravi Vij, MD, Mark A. Schroeder, MD, Geoffrey L. Uy, MD, Jingxia Liu, Rizwan Romee, MD
Journal: Blood
Blood (2016) 128 (22): 4696.
https://doi.org/10.1182/blood.V128.22.4696.4696
Published: 2016
Journal Articles

Chemotherapy Versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome Following Allogeneic Stem Cell Transplant: A Retrospective Review

Ibraheem H Motabi, MD, Jingxia Liu, PhD, Camille N. Abboud, MD FACP, Amanda F. Cashen, MD, Keith E. Stockler-Goldstein, MD, Geoffrey L. Uy, MD, Ravi Vij, MD, Peter Westervelt, MD PhD, John F. DiPersio
Journal: Blood
Blood (2014) 124 (21): 3944.
https://doi.org/10.1182/blood.V124.21.3944.3944
Published: 2014
Journal Articles

Impact of Remission Status on Outcomes in AML Patients ≥ 60 Years of Age after Allogeneic Stem Cell Transplantation

Pavan Bhamidipati, MD, Young Se Han, MD, John F. DiPersio, MD PhD, Keith E. Stockerl-Goldstein, MD, Jingxia Liu, PhD, Geoffrey L. Uy, MD, Peter Westervelt, MD PhD, Ravi Vij, MD, Mark A. Schroeder, MD, Camille N. Abboud, MD, Amanda F. Cashen, MD, Nusayba A Bagegni, MD, Rizwan Romee, MD
Journal: Blood
Blood (2014) 124 (21): 1263.
https://doi.org/10.1182/blood.V124.21.1263.1263
Published: 2014